Ablaze and Yonghe Pharma initiate development and manufacturing agreement for targeted radiopharmaceutical therapies
Yonghe as the CDMO partner will provide production process development and cGMP manufacturing services for Ablaze
Yonghe as the CDMO partner will provide production process development and cGMP manufacturing services for Ablaze
A committee of two Joint Drugs Controllers has been constituted at CDSCO to monitor the process of inspection, reporting, and subsequent action to ensure compliance to the Drugs & Cosmetics Act, 1940
As per the agreement, NSE-listed Vaishali Pharma Limited will take over the entire domestic and international marketing of Jark Pharma’s portfolio of quality based ayurvedic products
Global pharmaceutical company having a surgical business concept incepted in Dubai
The Halol facility was placed under Import Alert by USFDA.
The investment will enable the company to enter European markets as well as enhance margins in current markets
GMP-compliant documentation of all manufacturing steps for cell and gene therapies
It offers quick relief in various types of Coughs, Colds and Sore Throat,
Shilpa Medicare Ltd's finished dosage form manufacturing facility, Unit IV, situated at Pharma SEZ, Jadcherla, Telangana has received Health Canada GMP approval
With this QIP placement, the Dhanuka group, which took over the company in 2018, is also meeting its mandatory obligation to dilute 15 percent stake in the company by March 2023
Subscribe To Our Newsletter & Stay Updated